Articles dans des revues avec comité de lecture (220)
  1. 8. Fugger, G., Bartova, L., Dold, M., Fabbri, C., Fanelli, G., Zanardi, R., Kautzky, A., Zohar, J., Souery, D., Mendlewicz, J., Montgomery, S., Rujescu, D., Serretti, A., & Kasper, S. S. (2022). Evidence on sociodemographic and clinical correlates of antidepressant combination or augmentation with second-generation antipsychotics in major depressive disorder. Progress in neuro-psychopharmacology & biological psychiatry, 114, 110480. doi:10.1016/j.pnpbp.2021.110480
  2. 9. Fanelli, G., Domschke, K., Minelli, A., Gennarelli, M., Martini, P., Bortolomasi, M., Maron, E., Squassina, A., Kasper, S. S., Zohar, J., Souery, D., Montgomery, S., Albani, D., Forloni, G. L. G., Ferentinos, P., Rujescu, D., Mendlewicz, J., De Ronchi, D., Baune, B. B., Serretti, A., & Fabbri, C. (2022). A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response. European neuropsychopharmacology, 55, 86-95. doi:10.1016/j.euroneuro.2021.11.005
  3. 10. Bartova, L., Fugger, G., Dold, M., Kautzky, A., Swoboda, M. M. M., Rujescu, D., Zohar, J., Souery, D., Mendlewicz, J., Montgomery, S., Fabbri, C., Serretti, A., & Kasper, S. S. (2022). The Choice of Either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients With Major Depressive Disorder. The international journal of neuropsychopharmacology, 25(2), 118-127. doi:10.1093/ijnp/pyab066
  4. 11. Dold, M., Bartova, L., Fugger, G., Mitschek, M. M. M., Fabbri, C., Serretti, A., Mendlewicz, J., Souery, D., Zohar, J., Montgomery, S., & Kasper, S. S. (2022). Pregabalin augmentation of antidepressants in major depression - results from a European multicenter study. Journal of affective disorders, 296, 485-492. doi:10.1016/j.jad.2021.09.063
  5. 12. Fugger, G., Bartova, L., Fabbri, C., Fanelli, G., Dold, M., Swoboda, M. M. M., Kautzky, A., Zohar, J., Souery, D., Mendlewicz, J., Montgomery, S., Rujescu, D., Serretti, A., & Kasper, S. S. (2022). The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries. European archives of psychiatry and clinical neuroscience. doi:10.1007/s00406-021-01368-3
  6. 13. Carvalho Henriques, B., Buchner, A., Hu, X., Wang, Y., Yavorskyy, V., Wallace, K., Dong, R., Martens, K., Carr, M. M., Behroozi Asl, B., Hague, J., Sivapalan, S., Maier, W., Dernovsek, M. Z., Henigsberg, N., Hauser, J. W., Souery, D., Cattaneo, A., Mors, O., Rietschel, M., Pfeffer, G., Hume, S., & Aitchison, K. (2021). Methodology for clinical genotyping of CYP2D6 and CYP2C19. Translational Psychiatry, 11(1), 596. doi:10.1038/s41398-021-01717-9
  7. 14. Bartova, L., Fugger, G., Dold, M., Swoboda, M. M. M., Zohar, J., Mendlewicz, J., Souery, D., Montgomery, S., Fabbri, C., Serretti, A., & Kasper, S. (2021). Combining psychopharmacotherapy and psychotherapy is not associated with better treatment outcome in major depressive disorder - evidence from the European Group for the Study of Resistant Depression. Journal of Psychiatric Research, 141, 167-175. doi:10.1016/j.jpsychires.2021.06.028
  8. 15. Dold, M., Bartova, L., Fugger, G., Kautzky, A., Mitschek, M. M. M., Fabbri, C., Montgomery, S., Zohar, J., Souery, D., Mendlewicz, J., Serretti, A., & Kasper, S. S. (2021). Melancholic features in major depression – a European multicenter study. Progress in neuro-psychopharmacology & biological psychiatry, 110, 110285. doi:10.1016/j.pnpbp.2021.110285
  9. 16. Taliaz, D., & Souery, D. (2021). A new characterization of mental health disorders using digital behavioral data: Evidence from major depressive disorder. Journal of Clinical Medicine, 10(14), 3109. doi:10.3390/jcm10143109
  10. 17. Bartova, L., Dold, M., Fugger, G., Kautzky, A., Mitschek, M. M. M., Weidenauer, A., Handschuh, P. A., Frey, R., Mandelli, L., Zohar, J., Mendlewicz, J., Souery, D., Montgomery, S., Fabbri, C., Serretti, A., & Kasper, S. S. (2021). The Role of Relationship Status in Major Depressive Disorder - Results of the European Group for the Study of Resistant Depression. Journal of affective disorders, 286, 149-157. doi:10.1016/j.jad.2021.02.070
  11. 18. Crisafulli, C., Calabrò, M., Mandelli, L., Wang, S. M., Lee, S. J., Han, C., Patkar, A., Masand, P., Pae, C. U., Souery, D., Mendlewicz, J., & Serretti, A. (2021). Possible modulatory role of ARC gene variants in mood disorders. Clinical Psychopharmacology and Neuroscience, 19(1), 46-52. doi:10.9758/CPN.2021.19.1.46
  12. 19. Fabbri, C., Kasper, S., Zohar, J., Souery, D., Montgomery, S., Albani, D., Forloni, G. L. G., Ferentinos, P., Rujescu, D., Mendlewicz, J., De Ronchi, D., Riva, M. A., Lewis, C. C., & Serretti, A. (2021). Drug repositioning for treatment-resistant depression: Hypotheses from a pharmacogenomic study. Progress in neuro-psychopharmacology & biological psychiatry, 104, 110050. doi:10.1016/j.pnpbp.2020.110050
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Suivant >>